Dashboard
Manage Tickers

ANIX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ef-hutton-maintains-buy-on-anixa-biosciences-maintains-10-price-target
EF Hutton Maintains Buy on Anixa Bioscienc...
09/09/2024 15:54:23

EF Hutton analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.

anixa-biosciences-presents-ovarian-cancer-car-t-therapy-at-rivkin-center-aacr-15th-biennial-ovarian-cancer-research-symposium
Anixa Biosciences Presents Ovarian Cancer ...
09/03/2024 12:34:57

ef-hutton-initiates-coverage-on-anixa-biosciences-with-buy-rating-announces-price-target-of-10
EF Hutton Initiates Coverage On Anixa Bios...
08/07/2024 11:18:31

EF Hutton analyst Jason Kolbert initiates coverage on Anixa Biosciences (NASDAQ:ANIX) with a Buy rating and announces Price ...

anixa-biosciences-to-presentation-its-ovarian-cancer-car-t-clinical-trial-at-the-igcs-2024-annual-meeting-october-16-18-2024
Anixa Biosciences To Presentation Its Ovar...
07/29/2024 12:48:51

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatm...

anixa-biosciences-and-3-other-stocks-under-5-insiders-are-buying
Anixa Biosciences And 3 Other Stocks Under...
07/29/2024 11:13:50

hc-wainwright--co-reiterates-buy-on-anixa-biosciences-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Anix...
07/24/2024 10:20:26

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $7 price target.

anixa-biosciences-collaborator-cleveland-clinic-receives-decision-to-grant-notice-from-japan-patent-office-for-patent-titled-vaccine-adjuvants-and-formulations
Anixa Biosciences Collaborator, Cleveland ...
07/17/2024 12:07:49

anixa-biosciences-treats-sixth-patient-in-ongoing-phase-1-clinical-trial-of-chimeric-antigen-receptor-t-cell-therapy-for-ovarian-cancer
Anixa Biosciences Treats Sixth Patient In ...
06/24/2024 12:46:21

hc-wainwright--co-maintains-buy-on-anixa-biosciences-lowers-price-target-to-7
HC Wainwright & Co. Maintains Buy on Anixa...
06/10/2024 10:42:52

HC Wainwright & Co. analyst Yi Chen maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and lowers the price target fro...

anixa-biosciences-begins-treatment-of-fifth-patient-in-ovarian-cancer-car-t-clinical-trial
Anixa Biosciences Begins Treatment Of Fift...
05/21/2024 11:33:51

anixa-biosciences-partners-with-cleveland-clinic-to-develop-cancer-vaccines
Anixa Biosciences Partners With Cleveland ...
05/08/2024 12:27:48

anixa-biosciences-13d-filing-shows-president-coo--cfo-michael-catelani-reported-a-525-stake-in-the-co-as-of-april-30-2024
Anixa Biosciences 13D Filing Shows Preside...
05/03/2024 17:34:09

- SEC Filing

hc-wainwright--co-reiterates-buy-on-anixa-biosciences-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Anix...
03/21/2024 10:33:41

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

recap-anixa-biosciences-q1-earnings
Recap: Anixa Biosciences Q1 Earnings
03/12/2024 21:45:06

hc-wainwright--co-reiterates-buy-on-anixa-biosciences-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Anix...
02/13/2024 17:28:22

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

anixa-biosciences-initiates-dosing-in-second-cohort-of-ovarian-cancer-car-t-clinical-trial
Anixa Biosciences Initiates Dosing in Seco...
02/12/2024 12:33:39

 Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a clinical-stage biotechnology company focus...

anixa-biosciences-announces-japanese-patent-on-ovarian-cancer-vaccine-technology
Anixa Biosciences Announces Japanese Paten...
01/23/2024 13:06:35

Broad coverage extended to Japan and related regionsSAN JOSE, Calif., Jan. 23, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. (&#...

anixa-biosciences-reveals-updated-data-from-breast-cancer-vaccine-trial-says-exceeded-expectations
Anixa Biosciences Reveals Updated Data Fro...
12/07/2023 14:58:22

Anixa Biosciences Inc (NASDAQ: ANIX) announced new and updated results from the Phase 1 trial of its breast cancer vaccine. 

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/07/2023 13:07:04

hc-wainwright--co-reiterates-buy-on-anixa-biosciences-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Anix...
12/07/2023 11:28:07

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION